Cerity Partners
TNYA icon

Cerity Partners’s Tenaya Therapeutics TNYA Stock Holding History

Cerity Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-110,336
Closed -$67.4K – 2868
2025
Q2 		$67.4K Buy
110,336
+88,424
+404% +$45K ﹤0.01% 2529
2025
Q1 		$12.5K Buy
+21,912
New +$21.6K ﹤0.01% 2460

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Cerity Partners's TNYA Position: Q3 2025 in Review

Cerity Partners sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 110,336 shares — an estimated $67.4K sold.

Cerity Partners first reported a position in TNYA in Q1 2025 and held it in 2 quarters. The position peaked at $67.4K in Q2 2025. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

  • Cerity Partners reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cerity Partners sold 110,336 Tenaya Therapeutics shares in Q3 2025, an estimated $67.4K.
  • Cerity Partners first reported a position in Tenaya Therapeutics in Q1 2025 and held it in 2 quarters.
  • Cerity Partners's Tenaya Therapeutics position peaked at $67.4K in Q2 2025.
  • 91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.